VivaZome and Cytiva enter into an agreement on downstream technology for exosome purification
21 May 2020 VivaZome Therapeutics Pty Ltd (“VivaZome”) and Cytiva, formerly part of GE Healthcare Life Sciences, have entered into an agreement where Cytiva’s range of purification technologies, including Fibro, will be applied to VivaZome’s selected exosome fractions,…
Israel becomes first Middle Eastern market for Sienna’s hTERT IVD
21 May 2020 Sienna Cancer Diagnostics Ltd is pleased to announce the appointment of Zotal Ltd (“Zotal”) as its exclusive distributor in Israel. The distribution agreement provides Zotal with the right to sell Sienna’s hTERT IVD to pathology…
MCRI launches landmark study into children’s COVID-19 immune responses with assistance from Rio Tinto
19 May 2020 The Murdoch Children’s Research Institute (MCRI) has launched its COVID Immune research program to investigate COVID-19 effects on children’s immune systems. The new program, an Australian first, has been made possible with support from Rio Tinto,…
$32 million for the next generation of clinician researchers to pursue critical health and medical research
20 May 2020 The Australian Government will invest almost $32 million through the Medical Research Future Fund (MRFF) in world-leading health and medical research projects. 30 early- to mid-career researchers will be offered 5-year grants funded through the…
FDA allows Veyonda® Pre-IND Submission for COVID-19
19 May 2020 Noxopharm (ASX:NOX) today announces that on advice from the U.S. Food and Drug Administration (FDA), the Company has lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of Veyonda® in patients with SARS-CoV-2…
Supporting Victorian Universities
19 May 2020 The Victorian Government will make an unprecedented investment in local universities to protect jobs and support the state’s economic rebound from the coronavirus crisis. Minister for Training and Skills and Higher Education Gayle Tierney joined…
Four new projects announced for National Drug Discovery Centre
19 May 2020 Four research projects have been awarded generous Australian Government subsidies to fast-track their discoveries into new medicines using the National Drug Discovery Centre (NDDC) at The Walter and Eliza Hall Institute. The centre provides researchers…
Immunological scarring: new research reveals why your immune system can shut down
19 May 2020 Researchers have identified a molecular “switch” that triggers a powerful chain of events in response to severe bacterial or viral infections that could change how we manage patients in intensive care, including those with COVID-19.…
New Angel Groups Provide Lifeline To Early-Stage Startups
19 May 2020 More than $10 million in private sector capital is set to be unlocked to help over 40 early-stage Victorian startups reach their economic potential, thanks to funding announced by the Andrews Labor Government today. The…
Bosch puts fully automated mask-production lines into operation
15 May 2020 In the fight against coronavirus, Bosch has now turned its hand to the fully automated production of face masks. Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH, today launched the…
Case Study: Accelerating drug discovery at the Melbourne Biomedical Precinct
14 May 2020 33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and Medical Research Council (NHMRC) funding annually, more…
Public information key to combatting rising ‘superbug’ threat
14 May 2020 With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which…
